Presentation
9 March 2022 Quantitative tumor depth determination in fluorescence guided surgery
Author Affiliations +
Abstract
Fluorescence guided surgery has high potential for improved patient outcomes but often lacks quantification of fluorophore depth which is needed to determine surgical margins of solid tumors. To address this need, a dual wavelength excitation approach was applied that capitalizes on the wavelength-dependent attenuation of light in tissue to provide depth information independent of fluorophore concentration. A portable near infrared dual wavelength excitation fluorescence imaging system was built and tested using tissue mimicking phantoms and is currently being tested to determine breast tumor margin status in a first-in-human clinical trial investigating LS301, a novel near infrared tumor-targeted contrast agent.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Christine M. O'Brien, Kevin Bishop, Xiao Xu, Leonid Shmuylovich, Elizabeth Conley, Suman B. Mondal, Karen Nwosu, Haini Zhang, Kathleen Duncan, Steve Vanko, and Samuel Achilefu "Quantitative tumor depth determination in fluorescence guided surgery", Proc. SPIE PC11949, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XX, PC1194905 (9 March 2022); https://doi.org/10.1117/12.2614088
Advertisement
Advertisement
KEYWORDS
Luminescence

Tumors

Surgery

Near infrared

Optical properties

Tissue optics

Tissues

Back to Top